Walker Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$496K Buy
8,616
+94
+1% +$5.4K 0.25% 77
2026
Q1
$517K Buy
8,522
+103
+1% +$6K 0.28% 70
2025
Q4
$454K Buy
8,419
+131
+2% +$6.3K 0.24% 77
2025
Q3
$374K Buy
8,288
+99
+1% +$4.62K 0.21% 87
2025
Q2
$379K Buy
8,189
+130
+2% +$6.38K 0.22% 80
2025
Q1
$491K Buy
8,059
+72
+0.9% +$4.2K 0.3% 60
2024
Q4
$452K Buy
7,987
+44
+0.6% +$2.46K 0.28% 60
2024
Q3
$411K Buy
7,943
+115
+1% +$5.39K 0.25% 67
2024
Q2
$325K Buy
7,828
+1,371
+21% +$61.3K 0.22% 89
2024
Q1
$350K Buy
6,457
+450
+7% +$22.9K 0.23% 81
2023
Q4
$308K Buy
6,007
+2,000
+50% +$105K 0.22% 87
2023
Q3
$233K Buy
4,007
+13
+0.3% +$797 0.21% 81
2023
Q2
$255K Buy
3,994
+29
+0.7% +$1.95K 0.21% 73
2023
Q1
$275K Buy
3,965
+37
+0.9% +$2.61K 0.24% 65
2022
Q4
$283K Sell
3,928
-135
-3% -$10.2K 0.25% 59
2022
Q3
$289K Sell
4,063
-54
-1% -$3.92K 0.26% 52
2022
Q2
$317K Sell
4,117
-132
-3% -$10.1K 0.29% 53
2022
Q1
$310K Buy
4,249
+31
+0.7% +$2.08K 0.25% 58
2021
Q4
$263K Buy
+4,218
New +$247K 0.23% 66

Other funds holding BMY

Walker Asset Management's BMY Position: Q2 2026 in Review

Walker Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $5.4K and bringing the position to 8,616 shares worth $496K. The position accounts for 0.25% of the portfolio, ranked #77.

Walker Asset Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $517K in Q1 2026. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Walker Asset Management held 8,616 shares of Bristol-Myers Squibb worth $496K as of Q2 2026.
  • Walker Asset Management bought 94 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.4K.
  • Bristol-Myers Squibb made up 0.25% of Walker Asset Management's portfolio in Q2 2026, its #77 holding.
  • Walker Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Walker Asset Management's Bristol-Myers Squibb position peaked at $517K in Q1 2026.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.